Skip to main content

Advertisement

Log in

Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1 300 000 older people

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

To investigate whether institutionalization is associated with the use of antiepileptic drugs (AEDs) and to compare the association between use of AEDs and psychotropics in community-dwelling and institutionalized elderly, after adjustment for age, sex and co-morbidity (i.e. number of other drugs).

Methods

We analyzed data on age, sex and dispensed drugs for individuals aged ≥65 years registered in the Swedish Prescribed Drug Register from July to September 2008, record-linked to the Swedish Social Services Register (n = 1 345 273: 1 258 565 community-dwelling and 86 708 institutionalized elderly). Multivariate logistic regression analysis was used to analyze whether institutionalization and use of psychotropics (i.e. antipsychotics, anxiolytics, hypnotics/sedatives and antidepressants) were associated with the use of AEDs.

Results

AEDs were used by 2% of the community-dwelling and 9% of the institutionalized elderly. The most commonly used AEDs were carbamazepine, gabapentin, pregabalin, valproic acid and lamotrigine. Institutionalization was strongly associated with AED use (ORadjusted = 3.98; 95% CI 3.86–4.10). In community-dwelling elderly, AED use was associated with an increased probability of use of all types of psychotropics. However, among institutionalized elderly, the associations between use of AEDs and psychotropics showed a mixed pattern.

Conclusions

AED use seems to be common among Swedish institutionalized elderly, and institutionalization is a strong determinant of AED use. Our results may also indicate an off-label prescribing of AEDs as an alternative to psychotropics in the institutional setting. This finding needs to be confirmed by others and evaluated with respect to outcomes of this treatment in institutionalized elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tsiropoulos I, Gichangi A, Andersen M, Bjerrum L, Gaist D, Hallas J (2006) Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand 113:405–411

    Article  PubMed  CAS  Google Scholar 

  2. Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi AP, Musolino R, Spina E, Trifiro G (2007) Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000–2005. Eur J Neurol 14:1317–1321

    Article  PubMed  CAS  Google Scholar 

  3. Hauser WA (1992) Seizure disorders: the changes with age. Epilepsia 33[Suppl 4]:S6–S14

    Article  PubMed  Google Scholar 

  4. Hauser WA, Annegers JF, Rocca WA (1996) Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 71:576–586

    Article  PubMed  CAS  Google Scholar 

  5. Pugh MJ, Van Cott AC, Cramer JA, Knoefel JE, Amuan ME, Tabares J, Ramsay RE, Berlowitz DR (2008) Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000–2004. Neurology 70:2171–2178

    Article  PubMed  CAS  Google Scholar 

  6. Perucca E, Berlowitz D, Birnbaum A, Cloyd JC, Garrard J, Hanlon JT, Levy RH, Pugh MJ (2006) Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 68[Suppl 1]:S49–S63

    Article  PubMed  CAS  Google Scholar 

  7. Perucca E, Richens A (2001) Trials in the elderly. Epilepsy Res 45:149–151, discussion 153–144

    Article  PubMed  CAS  Google Scholar 

  8. Lackner TE, Cloyd JC, Thomas LW, Leppik IE (1998) Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use. Epilepsia 39:1083–1087

    Article  PubMed  CAS  Google Scholar 

  9. Harms SL, Eberly LE, Garrard JM, Hardie NA, Bland PC, Leppik IE (2005) Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J Am Geriatr Soc 53:1023–1028

    Article  PubMed  Google Scholar 

  10. Garrard J, Cloyd J, Gross C, Hardie N, Thomas L, Lackner T, Graves N, Leppik I (2000) Factors associated with antiepileptic drug use among elderly nursing home residents. J Gerontol A Biol Sci Med Sci 55:M384–M392

    Article  PubMed  CAS  Google Scholar 

  11. Garrard J, Harms S, Hardie N, Eberly LE, Nitz N, Bland P, Gross CR, Leppik IE (2003) Antiepileptic drug use in nursing home admissions. Ann Neurol 54:75–85

    Article  PubMed  Google Scholar 

  12. Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L (1998) An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc 46:1137–1141

    PubMed  CAS  Google Scholar 

  13. Galimberti CA, Magri F, Magnani B, Arbasino C, Cravello L, Marchioni E, Tartara A (2006) Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy. Epilepsy Res 68:1–8

    Article  PubMed  Google Scholar 

  14. Huying F, Klimpe S, Werhahn KJ (2006) Antiepileptic drug use in nursing home residents: a cross-sectional, regional study. Seizure 15:194–197

    Article  PubMed  Google Scholar 

  15. Berlowitz DR, Pugh MJ (2007) Pharmacoepidemiology in community-dwelling elderly taking antiepileptic drugs. Int Rev Neurobiol 81:153–163

    Article  PubMed  Google Scholar 

  16. Oteri A, Trifiro G, Gagliostro MS, Tari DU, Moretti S, Bramanti P, Spina E, Caputi AP, Arcoraci V (2010) Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004–07. Br J Clin Pharmacol 70:514–522

    Article  PubMed  Google Scholar 

  17. Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S (2007) Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48:2336–2344

    PubMed  Google Scholar 

  18. Henning OJ, Nakken KO (2010) Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients. Acta Neurol Scand 122 [Suppl 20] 18–22

    Google Scholar 

  19. Karouni M, Arulthas S, Larsson PG, Rytter E, Johannessen SI, Landmark CJ (2010) Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 66:1151–1160

    Article  PubMed  Google Scholar 

  20. Kessing LV, Harhoff M, Andersen PK (2007) Increased rate of treatment with antidepressants in patients with epilepsy. Epilepsy Behav 11:39–45

    Article  PubMed  Google Scholar 

  21. Mergener MA, Carr RM (2006) Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid. Wis Med J 105:36–39

    Google Scholar 

  22. Chen H, Deshpande AD, Jiang R, Martin BC (2005) An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiol Drug Saf 14:629–638

    Article  PubMed  Google Scholar 

  23. Konovalov S, Muralee S, Tampi RR (2008) Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr 20:293–308

    Article  PubMed  Google Scholar 

  24. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735

    Article  PubMed  Google Scholar 

  25. Lau HS, de Boer A, Beuning KS, Porsius A (1997) Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50:619–625

    Article  PubMed  CAS  Google Scholar 

  26. Johnell K, Fastbom J, Rosen M, Leimanis A (2007) Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 41:1243–1248

    Article  PubMed  Google Scholar 

  27. WHO (2010) Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Available at: http://www.whocc.no/. Accessed 21 Dec 2010

  28. National Board of Health and Welfare (2009) Care and services to elderly persons 30 June 2008 (in Swedish), Published online at: www.socialstyrelsen.se

  29. Mattsson P, Tomson T, Eriksson O, Brannstrom L, Weitoft GR (2010) Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients. Neurology 74:295–301

    Article  PubMed  CAS  Google Scholar 

  30. Johnell K, Fastbom J (2009) The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatry 24:731–738

    Article  PubMed  Google Scholar 

  31. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854–864

    Article  PubMed  CAS  Google Scholar 

  32. Johannessen Landmark C, Patsalos PN (2010) Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10:119–140

    Article  PubMed  CAS  Google Scholar 

  33. Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64:1868–1873

    Article  PubMed  CAS  Google Scholar 

  34. Alacqua M, Trifiro G, Spina E, Moretti S, Tari DU, Bramanti P, Caputi AP, Arcoraci V (2009) Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003–2005. Epilepsy Res 85:107–113

    Article  PubMed  Google Scholar 

  35. Hamer AM, Haxby DG, McFarland BH, Ketchum K (2002) Gabapentin use in a managed medicaid population. J Manag Care Pharm 8:266–271

    PubMed  Google Scholar 

  36. Kim Y, Wilkins KM, Tampi RR (2008) Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs Aging 25:187–196

    Article  PubMed  CAS  Google Scholar 

  37. Beghi M, Savica R, Beghi E, Nobili A, Garattini L (2009) Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue. Drugs Aging 26:157–168

    Article  PubMed  Google Scholar 

  38. Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y (2009) Seizures in Alzheimer disease: who, when, and how common? Arch Neurol 66:992–997

    Article  PubMed  Google Scholar 

  39. Haukka J, Suvisaari J, Tuulio-Henriksson A, Lonnqvist J (2007) High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 63:1069–1074

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the National Board of Health and Welfare for providing data. This study was supported financially by a grant from the Swedish Research Council (dnr 2007–5870).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kristina Johnell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnell, K., Fastbom, J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1 300 000 older people. Eur J Clin Pharmacol 67, 1069–1075 (2011). https://doi.org/10.1007/s00228-011-1051-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1051-2

Keywords

Navigation